BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22393393)

  • 1. Development of a bead-based multiplex genotyping method for diagnostic characterization of HPV infection.
    Chung MY; Kim YW; Bae SM; Kwon EH; Chaturvedi PK; Battogtokh G; Ahn WS
    PLoS One; 2012; 7(2):e32259. PubMed ID: 22393393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.
    Comar M; Iannacone MR; Casalicchio G; McKay-Chopin S; Tommasino M; Gheit T
    J Clin Microbiol; 2012 Dec; 50(12):4041-6. PubMed ID: 23035194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
    J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
    Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data.
    Martins TR; Mendes de Oliveira C; Rosa LR; de Campos Centrone C; Rodrigues CL; Villa LL; Levi JE
    Virol J; 2016 Aug; 13():138. PubMed ID: 27515763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
    Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
    J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
    Wang HY; Kim H; Park KH
    Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
    Castle PE; Gravitt PE; Solomon D; Wheeler CM; Schiffman M
    J Clin Microbiol; 2008 Jan; 46(1):109-17. PubMed ID: 17989194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z; Li Y; Chen A; Song M; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
    Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
    Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays.
    Albrecht V; Chevallier A; Magnone V; Barbry P; Vandenbos F; Bongain A; Lefebvre JC; Giordanengo V
    J Virol Methods; 2006 Nov; 137(2):236-44. PubMed ID: 16879879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
    Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
    Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.